IRAK1 and diabetes mellitus: These authors used a model of diabetes induced using the drug streptozotocin and identified decreased NFkB and MyD88 activity, along with IRAK-1 phosphorylation, leading to a decrease in circulating chemokines and cytokines in TLR2−/−, compared with wild-type, mice.